Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
3.25
Dollar change
+0.04
Percentage change
1.25
%
Index- P/E- EPS (ttm)-0.25 Insider Own24.18% Shs Outstand86.25M Perf Week14.04%
Market Cap154.18M Forward P/E- EPS next Y-0.49 Insider Trans0.00% Shs Float35.97M Perf Month8.70%
Income6.30M PEG- EPS next Q- Inst Own19.34% Short Float0.96% Perf Quarter-14.47%
Sales0.00M P/S- EPS this Y79.39% Inst Trans-8.42% Short Ratio11.07 Perf Half Y-15.36%
Book/sh2.37 P/B1.37 EPS next Y41.91% ROA1.31% Short Interest0.35M Perf Year-68.29%
Cash/sh0.01 P/C550.64 EPS next 5Y- ROE1.42% 52W Range2.63 - 10.94 Perf YTD-13.10%
Dividend Est.- P/FCF- EPS past 5Y- ROI8.64% 52W High-70.29% Beta0.08
Dividend TTM- Quick Ratio0.13 Sales past 5Y0.00% Gross Margin- 52W Low23.57% ATR (14)0.28
Dividend Ex-Date- Current Ratio0.13 EPS Y/Y TTM-213.73% Oper. Margin0.00% RSI (14)56.84 Volatility9.77% 9.10%
Employees2 Debt/Eq0.04 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-464.56% Payout0.00% Rel Volume0.72 Prev Close3.21
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 13 BMO Avg Volume31.30K Price3.25
SMA2010.26% SMA501.53% SMA200-43.20% Trades Volume22,594 Change1.25%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Initiated Jefferies Buy $5
Feb-20-24 04:05PM
Feb-08-24 08:30AM
Jan-29-24 08:00AM
Jan-23-24 09:04AM
08:15AM
08:00AM Loading…
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 08:00AM
Jan-02-24 08:00AM
Nov-13-23 08:00AM
Nov-06-23 04:05PM
08:00AM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
08:00AM Loading…
Sep-18-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-04-23 01:33PM
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chardon BenoitChief Commercial OfficerDec 12Option Exercise1.19165,539197,562199,183Dec 14 07:17 PM